the effect of gvhd on long-term outcomes after peripheral blood allogeneic stem cell transplantation from an hla-identical sibling in adult acute lymphocytic leukemia: a landmark analysis approach in competing risks.

نویسندگان

arash jalali department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran ; hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.

kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.

mahmood mahmoudi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran.

kazem mohammad department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran.

چکیده

allogeneic hematopoietic stem cell transplantation (hsct) is the most effective therapy to prevent relapse in acute lymphocytic leukemia (all). this benefit is affected by non-relapse mortality (nrm) due to complications such as graft versus host disease (gvhd). a new approach in analyzing time-dependent covariates in competing risks is landmark analysis. so, the aim of this study is to evaluate the effect of acute and chronic gvhd on long-term outcomes, relapse and nrm, after allogeneic hsct in adult all using landmark analysis. this study was conducted on 252 all patients who were allogeneic transplanted from an hla-identical sibling with peripheral blood (pb) as the source of stem cell from 2004 to 2012 and were followed-up until 2013. in the first 100 days after transplant, a landmark analysis on days +10, +11, +12, +17, +24, and +31 was applied to assess the effect of acute gvhd on early relapse and nrm. similarly, for patients alive and event-free at day +100 after transplant, a landmark analysis at time points day +101, months +4, +5, +6, +9, and +12 was applied to evaluate the effect of chronic gvhd on late relapse and nrm. five-year lfs and os were 35.0% (95% ci: 29.1, 42.2%) and 37.5% (95% ci: 31.3, 45.0%), respectively. five-year cumulative incidence of relapse was 44.5% (95% ci: 37.9, 51.0%) while this was 20.4% (95% ci: 15.4, 26.0%) for nrm. the landmark analysis in the first 100 days after transplant showed that the grade iii/iv of agvhd has a lower risk of relapse but higher risk of nrm after adjustment for the ebmt risk score. for patients alive at day +100, cgvhd had no significant effect on relapse. limited cgvhd had lower risk of nrm and after 6 month post-transplant the risk of nrm decreased and there were not important difference between the groups of cgvhd. using advanced models enables us to estimate the effects more precisely and ultimately make inference more accurately.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks

Allogeneic Hematopoietic stem cell transplantation (HSCT) is the most effective therapy to prevent relapse in acute lymphocytic leukemia (ALL). This benefit is affected by non-relapse mortality (NRM) due to complications such as graft versus host disease (GVHD). A new approach in analyzing time-dependent covariates in competing risks is landmark analysis. So, the aim of this study is to evaluat...

متن کامل

تأثیر GVHD مزمن بر بقا بیماران لوسمی میلوئیدی حاد پس از پیوند سلول‌های بنیادی خون محیطی از خواهر یا برادر با HLA مشابه بدون تخلیه سلول T

Background : Graft versus host disease (GVHD) is among major complications of allogeneic hematopoietic stem cells transplantation, and also is an important factor affecting the outcome of transplantation. An increased incidence of GVHD has been suggested following allogeneic peripheral blood stem cells (PBSC) transplantation, however, how this affects survival is not yet well clear. In this stu...

متن کامل

the ebmt risk score in the presence of graft versus host disease in allogeneic stem cell transplantation in adult acute myelogenous leukemia: a multistate model for competing risks.

the aim of this study was to assess the predictive effect of the ebmt risk score on the outcomes of allogeneic stem cell transplantation in a relatively homogenous group of acute myelogenous leukemia (aml) patients regarding the occurrence of acute and chronic graft versus host disease (gvhd). this historical cohort study included adult patients (≥ 15 years old) with aml (n=363) who received al...

متن کامل

بهبود بقا بیماران مبتلا به لوسمی لنفوبلاستیک حاد فاقد HLA-A3/11 برای KIR3DL2 دهنده پس از پیوند سلول های بنیادی خونساز از خواهر یا برادر با HLA مشابه بدون تخلیه سلول T

A potential factor influencing hematopoietic stem cells transplantation (HSCT) outcome is the presence of donor-derived alloreactive natural killer (NK) cells. This retrospective analysis studied the impact of NK alloreactivity based on the missing KIR ligand, for acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) patients undergoing non-T-cell depleted HLA-identical sibling HS...

متن کامل

HLA-identical sibling stem-cell transplantation in first-remission AML.

transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2006;91:513-521. 6. Druker BJ, Guilhot F, O' Brien S, et al. Five-year follow-up of patients receiving ima-tinib for chronic myeloid leukemia. In t...

متن کامل

Remission of IgA nephropathy after allogeneic peripheral blood stem cell transplantation followed by immunosuppression for acute lymphocytic leukemia.

We report a case with immunoglobulin A (IgA) nephropathy, showing IgA deposition which disappeared after peripheral blood stem cell transplantation (PBSCT) for acute lymphocytic leukemia (ALL). In 1996, a 28-year-old man was diagnosed with IgA nephropathy by renal biopsy. Steroid therapy improved proteinuria from 3 g/day to 1 g/day. In 2003, he received PBSCT following the initial therapy for A...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of hematology-oncology and stem cell research

جلد ۸، شماره ۲، صفحات ۱-۸

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023